After rights were sold to MGI. Believe the rights were sold in 2004. Will confirm and post. However the current projection has been around for at least 6 months and it may have been estimate before the first delay on Dacogen requested additional information prior to approval. That delay may have to be factored in...I will give the analyst the timeline of approval of May 06. So if he's correct May 07 would be the ending time period. The valuation of $24 I think is a stretch. We would have to see a filing for approval AML U.S. and MDS EU before years end and possible approval by May? That news and the markets anticipation could maybe put SUPG valuation at $10-$14. My view.